Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150021/S061

Freestyle Libre Pro Flash Glucose Monitoring System

Abbott Diabetes Care, Inc. · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONP150021/S061

What did the FDA decide?

The record for P150021/S061 describes a 30-day notice under reason code "Process Change - Manufacturer/Sterilizer/Packager/Supplier." The reported change is "addition of a secondary supplier and manufacturer for subcomponents and subassemblies for sensor kits." The filing identifies the sensor as a component of the FreeStyle Libre 14-day and FreeStyle Libre Pro Flash Glucose Monitoring Systems, so the stated scope concerns sensor-kit subcomponents and subassemblies rather than the complete systems.

The identifier links this notice to prior PMA P150021 as a supplement, not a new approval of any whole system. The decision code OK30 and date 2026-09-01 appear in the supplied record, but the text gives no details on which subcomponents or subassemblies, which supplier or manufacturer, or what evidence supported the change; it is a sponsor-stated purpose, not independent proof of safety or clinical effectiveness.

FDA approval order statement

addition of a secondary supplier and manufacturer for subcomponents and subassemblies for sensor kits. The sensor is a component of the FreeStyle Libre 14-day and FreeStyle Libre Pro Flash Glucose Monitoring Systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Chemistry
Decision date
Sep 1, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150021/S061
Regulatory pathway
PMA supplement
Product code
MDS
Decision code
OK30
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, glucose, invasive.

Product code
MDS
FDA device class
3

For the original device and its historical approval scope, see PMA P150021. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150021 · Original PMA

    FREESTYLE LIBRE PRO FLASH GLUCOSE MONITORING SYSTEM

  2. P150021/S061 received

    Application receipt date recorded by FDA.

  3. P150021/S061 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P150021. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150021

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Diabetes Care, Inc.PMA approvalSep 23, 2016FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Diabetes Care, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1360 S. Loop Rd., Alameda, CA, 94502

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records